Abstract
This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.
Publication types
-
Randomized Controlled Trial
MeSH terms
-
Adolescent
-
Adult
-
CA-125 Antigen / blood*
-
Contraceptive Agents, Female / administration & dosage
-
Endometriosis / blood*
-
Endometriosis / drug therapy*
-
Equipment Failure Analysis
-
Female
-
Humans
-
Intrauterine Devices, Medicated*
-
Levonorgestrel / administration & dosage*
-
Treatment Outcome
Substances
-
CA-125 Antigen
-
Contraceptive Agents, Female
-
Levonorgestrel